companydata.dkACESION PHARMA ApS: Financial statements 2012
CVR: 34083738
ACESION PHARMA ApS (CVR 34083738) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -1,313,935 and a net result of DKK -2,068,513. Equity amounted to DKK 1,951,483. The solvency ratio was 74.2%.
- Gross Profit
- -1,313,935 kr.
- Profit/Loss
- -2,068,513 kr.
- Equity
- 1,951,483 kr.
- Total Assets
- 2,629,402 kr.
How creditworthy is ACESION PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout ACESION PHARMA ApS
ACESION PHARMA ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Gaarsdal Holst. The company's owners include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP. The company has 14 employees. In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity amounted to DKK 276,067,000.